Tetracycline-regulated mouse models of cancer

Elizabeth S Yeh1, Ann Vernon-Grey1, Heather Martin1

  • 1Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104.

Insights

Genetically engineered mouse models (GEMMs) offer insights into gene function but have limitations. Tetracycline-dependent systems overcome these, providing a powerful tool for studying complex diseases like cancer.

Area of Science:

  • Mammalian genetics
  • Molecular biology
  • Disease modeling

Background:

  • Genetically engineered mouse models (GEMMs) are crucial for studying gene function in development and disease.
  • Traditional transgenic models have limitations in temporal and spatial control of gene expression.
  • Existing inducible systems often cause toxic side effects.

Purpose of the Study:

  • To overcome limitations of traditional transgenic models.
  • To develop improved inducible systems for gene function studies.
  • To facilitate the modeling of complex diseases, particularly cancer.

Main Methods:

  • Development of conditional and inducible mouse model systems.
  • Utilizing tetracycline (tet)-dependent regulatory systems.
  • Evaluating gene expression control for temporal and spatial accuracy.

Main Results:

  • Tetracycline-dependent systems circumvented issues associated with toxic inducer compounds.
  • These systems offer precise temporal and spatial control over transgene expression.
  • Widespread adoption of tet-dependent systems for cancer progression modeling.

Conclusions:

  • Tet-dependent systems represent a significant advancement in creating sophisticated GEMMs.
  • These inducible systems are invaluable for dissecting complex biological processes.
  • The technology enables more accurate modeling of cancer and other diseases.